09:47 AM EST - Avicanna Inc. : Announced a corporate update and preliminary financial results of Q2-2023. Revenues were approximately $3.3M representing an approximately 200% increase over Q1-2023 revenues of $1.2M, this includes approximately $2.5M in sales arising from the Medical Cannabis by Shoppers platform since May 29, 2023. Avicanna Inc.
shares T.AVCN are trading down $0.01 at $0.29.
